Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Healthcare

igrnews

Human Papillomavirus Testing Market – Global Industry Analysis, Size, Share, Trends and Forecast 2018 – 2024

Healthcare Apr 21, 2019 at 17:28

Human Papillomavirus Testing Market – Global Industry Analysis, Size, Share, Trends and Forecast 2018 – 2024

We have produced a new premium report Human Papillomavirus Testing Market. The report covers the analysis of global as well as regional markets of Human Papillomavirus Testing. The objective of the study is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years. The report also deep dives into the sub-segments of Human Papillomavirus Testing Market by product (consumables and systems), end-user (hospitals, physicians’ office laboratories, and clinical diagnostic laboratories) through main geographies in the Global Market such as North America, Europe, Asia-Pacific and RoW.

The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the Human Papillomavirus Testing Market during the said period. The report also provides market attractiveness analysis, by geography, and market share analysis, by key players respectively. Some of the prominent participants in the Global Human Papillomavirus Testing Market are Cepheid, Abbott Laboratories, Arbor Vita, Roche Diagnostics, Genera Biosystems, Breakspear Medical, IncellDx, Delphi Bioscience, Fujirebio Diagnostics, and OralDNA Labs.

Co-Testing with HPV & Pap Tests

Co-testing with HPV & Papa tests is one of the recent trends in the global Human Papillomavirus Testing market. Moreover, this trend is further anticipated to drive the global Human Papillomavirus Testing market over the forecast period. Furthermore, the Pap test detects abnormal cells that may develop into cancer if left untreated well as HPV co-test detect HPV infections that cause cell abnormalities. These are the two prime reasons responsible for the growth of this trend.

Growing Prevalence of Cervical Cancer

Growing prevalence of cervical cancer and early detection to prevent this infection are the key factors responsible for the growth of the global Human Papillomavirus Testing market. Moreover, HPV is the most common sexually transmitted infection that affects both men and women. Cervix cell changes are caused by human papillomavirus.

North America Region is the Largest Consumer Among the Geographies Followed by Europe while APAC to grow at the highest CAGR

The global Human Papillomavirus Testing market has been dominated by the North America region over the historic period 2015-16 followed by Europe. Growing cases of cervical cancer and rising initiatives from the government regarding the infection as well as HPV testing are the prime factor responsible for the growth of Human Papillomavirus Testing market in this region. Furthermore, the Asia-Pacific region is expected to grow at the highest CAGR over the period of 2018 to 2024. Moreover, the growing prevalence of HPV infections and raising awareness among the population are anticipated to boost the market for Human Papillomavirus Testing.

The companies covered in the report include Cepheid, Abbott Laboratories, Arbor Vita, Roche Diagnostics, Genera Biosystems, Breakspear Medical, IncellDx, Delphi Bioscience, Fujirebio Diagnostics, and OralDNA Labs.